RXRX · Recursion Pharmaceuticals, Inc. · Executive Compensation

$3.70 +0.12 (+3.35%) At close · Oct 23

Russell 2000 member Rebalance outlook locked

Market Cap

$1.98B

535.34M

Volume · Oct 23 19.08M Avg daily vol (3M) 21.75M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Gibson	former Chief Executive Officer and President and current Chair of the Board	$680,000	—	$3,808,302	$4,846,699	$256,777	$15,731	$9,607,508
Christopher C. Gibson	former Chief Executive Officer and President and current Chair of the Board	$680,000	—	$3,808,302	$4,846,699	$256,777	$15,731	$9,607,508
Najat Khan	current Chief Executive Officer and President	$600,000	—	$1,944,547	$2,501,058	$256,777	$46,683	$5,349,065
Ben Taylor	Chief Financial Officer	$538,680	—	$253,881	$323,110	$205,226	$7,586	$1,328,483

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Najat Khan	Chief R&D and Chief Commercial Officer	$285,000	$500,000	$3,647,774	$4,592,021	$115,824	$54,185	$9,194,805
Christopher Gibson	Chief Executive Officer	$600,000	—	$3,364,500	$4,274,816	$241,865	$18,405	$8,499,587
Christopher C. Gibson	Chief Executive Officer	$600,000	—	$3,364,500	$4,274,816	$241,865	$18,405	$8,499,587
Ben Taylor	Chief Financial Officer	$53,392	—	$2,255,389	$5,662,543	$200,327	—	$8,171,651
Tina Marriott	Former Chief Operating Officer and President	$530,000	—	$2,259,736	$2,871,148	$213,648	$19,072	$5,893,604
Michael Secora	Former Chief Financial Officer	$475,000	—	$1,757,577	$2,233,116	—	$577,813	$5,043,506
David Mauro	Chief Medical Officer	$525,000	—	$502,159	$638,032	$211,626	$56,773	$1,933,590

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	Chief Executive Officer	$560,833	—	$3,478,140	$4,328,352	$224,483	$21,400	$8,613,209
Christopher Gibson	Chief Executive Officer	$560,833	—	$3,478,140	$4,328,352	$224,483	$21,400	$8,613,209
Tina Marriott	Former Chief Operating Officer and President	$485,733	—	$1,855,872	$2,309,529	$194,419	$22,092	$4,867,645
Michael Secora	Former Chief Financial Officer	$435,583	—	$1,730,759	$2,153,839	$174,369	$19,830	$4,514,381
David Mauro	Chief Medical Officer	$303,333	—	$1,672,553	$2,181,756	$121,634	$33,190	$4,312,466
Shafique Virani	Former Chief Corporate Development Officer	$520,417	—	$908,463	$1,130,537	$208,442	$36,182	$2,804,040

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher C. Gibson	Chief Executive Officer	$497,500	—	$2,573,043	$3,047,682	$185,478	$12,200	$6,315,903
Christopher Gibson	Chief Executive Officer	$497,500	—	$2,573,043	$3,047,682	$185,478	$12,200	$6,315,903
Tina Marriott	Former Chief Operating Officer and President	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,762,240
Tina Marriott Larson	Chief Operating Officer and President	$437,800	—	$984,017	$1,165,534	$163,289	$11,600	$2,750,640
Michael Secora	Former Chief Financial Officer	$348,250	—	$721,107	$845,127	$129,834	$46,104	$2,090,422
Shafique Virani	Former Chief Corporate Development Officer	$488,333	—	$497,181	$588,894	$181,906	$11,600	$1,767,914
Ramona Doyle	Chief Medical Officer	$167,933	—	$475,848	$563,625	—	$359,058	$1,207,406

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shafique Virani	Former Chief Corporate Development Officer	$500,000	—	—	—	$175,000	$13,174	$688,174
Christopher C. Gibson	Chief Executive Officer	$485,417	—	—	—	$175,000	$13,174	$673,591
Christopher Gibson	Chief Executive Officer	$485,417	—	—	—	$175,000	$13,174	$673,591
Ramona Doyle	Chief Medical Officer	$440,282	—	—	—	$154,000	$13,174	$607,456
Tina Marriott Larson	Chief Operating Officer and President	$428,771	—	—	—	$154,000	$13,174	$595,945
Tina Marriott	Chief Operating Officer and President	$428,771	—	—	—	$154,000	$13,174	$595,945
Michael Secora	Chief Financial Officer	$307,708	$63,460	—	—	$126,000	$13,174	$510,342

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Secora	Chief Financial Officer	$170,833	$63,000	—	$3,431,798	$15,357	$37,500	$3,718,488
Christopher C. Gibson	Chief Executive Officer	$269,643	$13,000	—	$2,268,661	$20,444	$12,700	$2,584,448
Christopher Gibson	Chief Executive Officer	$269,643	$13,000	—	$2,268,661	$20,444	$12,700	$2,584,448
Shafique Virani	Chief Corporate Development Office	$413,541	$13,000	—	$991,749	$28,158	$20,523	$1,466,974
Ramona Doyle	Chief Medical Officer	$3,666	—	—	$1,134,331	—	—	$1,137,997
Tina Marriott Larson	Chief Operating Officer and President	$408,192	$13,000	—	$226,866	$30,070	$12,700	$690,828

Executive changes

Person	Role	Change	Effective	Filed
Vicki Goodman, M.D.	Chief Medical Officer	Appointed	2026-04-06	2026-03-25
Robert Hershberg, M.D., Ph.D.	Vice Chair and Lead Independent Director	Appointed	2026-01-01	2025-11-05
Christopher Gibson, Ph.D.	Chair of the Board	Appointed	2026-01-01	2025-11-05
Najat Khan, Ph.D.	Chief Executive Officer and President	Appointed	2026-01-01	2025-11-05
Namandjé Bumpus	Class III Director	Appointed	2025-03-15	2025-03-18
Elaine Sun	Class III Director	Appointed	2025-03-15	2025-03-18
Matthew Kinn	Chief Business Officer	Appointed	2024-11-20	2024-11-20
Kristen Rushton	Chief Operating Officer	Appointed	2024-11-20	2024-11-20
Lina Nilsson	Senior Vice President, Head of Platform	Appointed	2024-11-20	2024-11-20
Christopher Gibson	President of the Company	Appointed	2024-11-20	2024-11-20
Ben Taylor	Chief Financial Officer of the Company and President of Recursion UK	Appointed	2024-11-20	2024-11-20
Franziska Michor	Class II Director	Appointed	2024-11-20	2024-11-20
David Hallett	Chief Scientific Officer	Appointed	—	2024-08-08
Chris Gibson	CEO of the combined company	Appointed	—	2024-08-08
Zachary Bogue	Chair of the Audit Committee	Appointed	2024-08-12	2024-08-08
Terry-Ann Burrell	member of the Company's board and Chair of its Audit Committee	Resigned	2024-08-12	2024-08-08
Najat Khan, Ph.D.	Class II Director	Appointed	2024-04-16	2024-04-16
Matthew Kinn	Senior Vice President, Business Development and Corporate Initiatives	Appointed	2024-02-06	2024-02-07
Shafique Virani	Senior Strategic Advisor	Appointed	2024-02-06	2024-02-07
David Mauro, M.D., Ph.D.	Chief Medical Officer	Appointed	2023-06-01	2023-05-17

Leadership

Christopher C. Gibson CEO, Board Member
Najat Khan CEO
Najat Khan, Ph.D. CEO, Board Member
Christopher Gibson, Ph.D. Chairman
Robert Hershberg, M.D., Ph.D. Chairman
Ben Taylor CFO
Kristen Rushton COO
Tina Marriott COO
David Hallett CTO, Board Member
Blake Borgeson Board Member
Dean Y. Li Board Member
Elaine Sun Board Member
Franziska Michor, Ph.D. Board Member
Namandjé Bumpus Board Member
Robert Hershberg Board Member
Zachary Bogue Board Member
Zavain Dar Board Member

Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 51 filings 51 filers Visit website Investor relations